Investing.com
Published Apr 04, 2024 10:18
"We are very pleased to be partnering with the stellar leadership of the Department of Health -
The finalists were selected from a pool of exceptional candidates across more than 20 countries and represent a diverse range of companies and research institutions developing innovative therapeutic solutions. Each finalist has demonstrated a commitment to advancing healthcare through creativity and groundbreaking research, with the ultimate goal of addressing unmet patient need for diseases of prevalence in the
The finalists will be judged by an esteemed panel, which includes:
"We are grateful to these preeminent scientists and business leaders for coming to
In addition to the pitch competition, where winners will ultimately be awarded, the summit will feature keynote speeches and networking opportunities to provide attendees with investment opportunities and valuable insights into the future of life sciences innovation. Learn more about the finalists and summit here.
About J.P. Morgan Life Sciences Private Capital
J.P. Morgan Life Sciences Private Capital is a venture capital and growth equity investment team within J.P. Morgan Global Alternatives, founded in late 2022. Life Sciences Private Capital launched its first early-stage biotechnology venture capital fund in early 2023, focused on building "move-the-needle" innovations that will ultimately improve quality of lives worldwide. The group aims to leverage J.P. Morgan's market position in healthcare investment banking and business banking, robust relationships with the largest pharmaceutical and life sciences companies, and the tenure of the Life Sciences Private Capital investment team and strategic advisors to form, capitalize, and support leading innovative life sciences companies.
For more information: J.P. Morgan Life Sciences Private Capital press release.
About J.P. Morgan Asset Management
J.P. Morgan Asset Management, with assets under management of
J.P. Morgan Asset Management is the marketing name for the asset management business of JPMorgan Chase & Co. (NYSE:JPM) and its investment advisor affiliates worldwide.
About Blue Horizon Advisors
Blue Horizon Advisors is the independent private investment arm of a leading, multi-billion dollar single
BHLS is committed to enhancing health through research and development of innovative therapies and diagnostic tools to improve and prolong lives. BHLS is poised to execute its strategic vision through a multifaceted approach, encompassing strategic acquisitions, robust in-house development initiatives, dynamic joint ventures with global industry leaders / innovators to foster knowledge exchange, and pivotal collaborations with key stakeholders in our ecosystem, including esteemed hospitals, renowned universities, regulatory authorities as well as local and global investment houses.
Written By: Investing.com
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.